Science of Traditional Chinese Medicine2025，Vol.3Issue(2)：P.97-112,16.DOI:10.1097/st9.0000000000000070
Drug innovation via integration of traditional Chinese and Western medicine
Zhineng Li 1Le Yang 2Ling Kong 1Hui Sun 1Ye Sun 2Xiangmei Chen 3Fengting Yin 1Guangli Yan 1Xijun Wang4
作者信息
- 1. State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine,National Chinmedomics Research Center,National TCM Key Laboratory of Serum Pharmacochemistry,Metabolomics Laboratory,Department of Pharmaceutical Analysis,Heilongjiang University of Chinese Medicine,Harbin,China
- 2. State Key Laboratory of Dampness Syndrome,The Second Affiliated Hospital Guangzhou University of Chinese Medicine,Guangzhou,China
- 3. Department of Nephrology,First Medical Center of Chinese PLA General Hospital,Nephrology Institute of the Chinese People''s Liberation Army,National Key Laboratory of Kidney Diseases,National Clinical Research Center for Kidney Diseases,Beijing Key Laboratory of Kidney Disease Research,Beijing,China
- 4. State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine,National Chinmedomics Research Center,National TCM Key Laboratory of Serum Pharmacochemistry,Metabolomics Laboratory,Department of Pharmaceutical Analysis,Heilongjiang University of Chinese Medicine,Harbin,China State Key Laboratory of Dampness Syndrome,The Second Affiliated Hospital Guangzhou University of Chinese Medicine,Guangzhou,China
- 折叠
摘要
关键词
Drug innovation/Traditional Chinese medicine/Western medicine/Research strategy/Multitarget drugs分类
医药卫生引用本文复制引用
Zhineng Li,Le Yang,Ling Kong,Hui Sun,Ye Sun,Xiangmei Chen,Fengting Yin,Guangli Yan,Xijun Wang..Drug innovation via integration of traditional Chinese and Western medicine[J].Science of Traditional Chinese Medicine,2025,3(2):P.97-112,16.基金项目
supported by the Heilongjiang Province Key Research and Development Plan(No.2022ZX02C04). （No.2022ZX02C04）
